Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
30
Number of overlapping holdings
28.6%
% of BMED's 115 holdings also in WDNA
35.7%
% of WDNA's 90 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 1.9% | 1.9% |
|
NATERA INC | 1.5% | 3.7% | 1.5% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 1.5% | 1.5% |
|
SAREPTA THERAPEUTICS INC | 1.4% | 1.4% | 1.4% |
|
DANAHER CORP | 1.3% | 1.4% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to WDNA
|
BOSTON SCIENTIFIC CORP | 4.9% |
|
INTUITIVE SURGICAL INC | 4.9% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
ABBVIE INC | 3.1% |
|
LONZA GROUP AG-REG | 2.7% |
|
ABBOTT LABORATORIES | 2.7% |
 |
ARGENX SE ADR | 2.4% |
 |
MEDTRONIC PLC | 2.3% |
|
UCB SA | 2.2% |
|
WATERS CORP | 2.0% |
BMED Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.0% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
VERICEL CORPORATION | -2.6% |
|
NATERA INC | -2.2% |
|
VERACYTE INC | -2.1% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
BRIDGEBIO PHARMA, INC. | -1.8% |
|
BLUEPRINT MEDICINES CORP. | -1.8% |
|
NOVARTIS AG | -1.7% |